According to Rich Coutinho of CBS New York, it’s …
Chemistry in the clubhouse.
It can extend winning streaks and snap losing streaks. The Mets have great chemistry, and that’s been been of the biggest reasons New York sits in second place in the competitive NL East.
And here I thought it was because of an MVP-caliber season from David Wright, offensive contributions from everyone else besides Ike Davis that are exceeding expectations, a resurgent Johan Santana helping the pitching look respectable when it was anticipated to be awful and an great deal of good fortune which has allowed the team to out-perform their Pythagorean record by a full five games.
But hey, if you wanna go with “chemistry,” be my guest.
The Cubs announced on Tuesday evening that the club signed pitcher Drew Smyly to a two-year contract. Ken Rosenthal of The Athletic reports the contract is for $10 million total and allows Smyly to earn another $7 million with performance bonuses. Smyly was non-tendered by the Mariners at the beginning of the month and became a free agent.
Smyly, 28, underwent season-ending Tommy John surgery in late June. He’s expected to miss, at minimum, the first half of the 2018 season. The Cubs are hoping he can contribute to a playoff push in the latter half of the season as well as in 2019.
Smyly didn’t pitch at all in 2017. When he was healthy the season prior, he made 30 starts for the Rays and put up a 4.88 ERA and a 167/49 K/BB ratio in 175 1/3 innings.